Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer.
OBJECTIVE
We sought to (1) describe associations between measures of tumor perfusion by dynamic contrast-enhanced breast magnetic resonance imaging (DCE-MRI), blood flow by (15)O-water positron emission tomography (PET) and metabolism by (18)F-fluorodeoxyglucose ((18)F)-FDG PET and (2) improve our understanding of tumor enhancement on MRI through independent measures of tumor metabolism and blood flow.


METHODS
We performed a retrospective analysis of the existing PET and MRI databases from the Departments of Nuclear Medicine and Radiology. We identified patients with locally advanced breast cancer who underwent (15)O-water/(18)F-FDG PET within 1 month of clinical DCE-MRI between February 2004 and August 2006. The (15)O-water PET blood flow and (18)F-FDG metabolic rate and tissue transport constant (K(1)) in the primary malignancy were calculated. DCE-MRI peak percent enhancement and peak signal enhancement ratio (SER) were measured for each tumor. Correlations and regression analysis of these variables were performed.


RESULTS
Fifteen patients with complete PET and DCE-MRI data were included in the analysis cohort. Peak SER correlated significantly with blood flow (r = 0.73, P = .002) and K(1) (r = 0.76, P = .001). However, peak SER did not correlate significantly with FDG metabolic rate (r = 0.44, P = .101). There were no significant correlations between peak percent enhancement and any of the PET parameters.


CONCLUSIONS
Our findings suggest that tumor perfusion, represented by (15)O-water PET blood flow, is an important factor in the MRI enhancement of locally advanced breast cancer. A lack of correlation of FDG metabolic rate with blood flow and DCE-MRI kinetics suggests that (18)F-FDG PET provides complementary metabolic information independent of vascular factors.
Eby
Peter R
PR
Department of Radiology, University of Washington, Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G3-200, Seattle, WA 98109-1023, USA. preby@u.washington.edu
Partridge
Savannah C
SC
White
Steven W
SW
Doot
Robert K
RK
Dunnwald
Lisa K
LK
Schubert
Erin K
EK
Kurland
Brenda F
BF
Lehman
Constance D
CD
Mankoff
David A
DA
D001783:Blood Flow Velocity; D001943:Breast Neoplasms / Q000098:blood supply / Q000000981:diagnostic imaging* / Q000378:metabolism*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009389:Neovascularization, Pathologic / Q000000981:diagnostic imaging* / Q000378:metabolism*; D010104:Oxygen Radioisotopes / Q000493:pharmacokinetics*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D014867:Water / Q000378:metabolism
D010104:Oxygen Radioisotopes; D019275:Radiopharmaceuticals; D014867:Water
J Clin Oncol. 2006 Feb 10;24(5):769-77
16391297
Magn Reson Imaging Clin N Am. 1999 May;7(2):411-20, x
10382170
Magn Reson Med. 1993 May;29(5):616-22
8505897
J Cereb Blood Flow Metab. 1985 Jun;5(2):179-92
3988820
Ann Neurol. 1979 Nov;6(5):371-88
117743
J Clin Oncol. 2000 Apr;18(8):1676-88
10764428
Radiology. 1990 Sep;176(3):791-9
2389038
Circ Res. 1979 Jan;44(1):127-37
363301
Acta Radiol. 2003 Jul;44(4):373-8
12846686
Cancer Invest. 1998;16(4):225-30
9589031
J Comput Assist Tomogr. 2002 Jul-Aug;26(4):510-4
12218810
Breast Cancer Res Treat. 2005 May;91(1):1-10
15868426
Magn Reson Imaging Clin N Am. 1994 Nov;2(4):633-58
7489314
AJR Am J Roentgenol. 2000 Oct;175(4):1029-33
11000158
Radiology. 2007 Sep;244(3):727-35
17709827
Lancet Oncol. 2003 Dec;4(12):759
14662432
Lancet. 1984 Jan 21;1(8369):131-4
6140443
J Nucl Med. 2002 Apr;43(4):500-9
11937594
J Magn Reson Imaging. 1999 Sep;10(3):260-6
10508285
J Nucl Med. 2004 Nov;45(11):1829-37
15534051
Clin Cancer Res. 2006 Oct 1;12(19):5659-67
17020967
J Neurochem. 1977 May;28(5):897-916
864466
J Nucl Med. 2003 Nov;44(11):1806-14
14602864
J Clin Oncol. 1993 Nov;11(11):2101-11
8229124
Eur Radiol. 2001;11(10):2058-70
11702142
Ann Oncol. 2006 Sep;17(9):1393-8
16788001
J Magn Reson Imaging. 2007 Sep;26(3):615-23
17729334
Radiology. 1990 Dec;177(3):633-41
2243962
J Clin Oncol. 1995 Jun;13(6):1470-7
7751894
Radiology. 1999 Apr;211(1):101-10
10189459
NMR Biomed. 2002 Apr;15(2):154-63
11870911
Breast J. 1999 Jan;5(1):13-21
11348250
Cancer Res. 1992 Mar 15;52(6):1592-7
1540969
Radiology. 2006 May;239(2):361-74
16543585
Magn Reson Med. 2004 Aug;52(2):420-9
15282828
Cancer. 2008 Jan 1;112(1):17-26
18000804
Magn Reson Med. 2000 Sep;44(3):450-6
10975898
J Clin Oncol. 2000 Apr;18(8):1689-95
10764429
Eur Radiol. 2003 Jan;13(1):80-7
12541113
Magn Reson Imaging. 2007 Apr;25(3):319-27
17371720
Radiology. 2004 Dec;233(3):830-49
15486214
Acad Radiol. 2004 Oct;11(10):1115-24
15530804
Eur Radiol. 2003 Jul;13(7):1635-44
12835979
Microcirculation. 2004 Jul-Aug;11(5):387-96
15280064
Stud Health Technol Inform. 1999;62:259-60
10538368
Eur J Nucl Med Mol Imaging. 2003 Feb;30(2):274-80
12552346
Breast Cancer Res Treat. 2004 Jan;83(1):67-76
14997056
AJR Am J Roentgenol. 2005 Jun;184(6):1774-81
15908529
Magn Reson Med. 2007 Sep;58(3):572-81
17685424